UCSF, Oregon Health & Science University and StemCells researchers have shown that neural stem cell transplants can remyelinate axons and treat myelination disorders including Pelizaeus-Merzbacher disease. The biotech is planning a Phase II study of neural stem cell transplantation in the indication.